PT117825A - SILA-ANALOGS OF VITAMIN D, METHOD OF PRODUCTION OF SAID COMPOUNDS, USES THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUNDS - Google Patents

SILA-ANALOGS OF VITAMIN D, METHOD OF PRODUCTION OF SAID COMPOUNDS, USES THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUNDS

Info

Publication number
PT117825A
PT117825A PT117825A PT11782522A PT117825A PT 117825 A PT117825 A PT 117825A PT 117825 A PT117825 A PT 117825A PT 11782522 A PT11782522 A PT 11782522A PT 117825 A PT117825 A PT 117825A
Authority
PT
Portugal
Prior art keywords
analogs
compounds
vitamin
vdr
sila
Prior art date
Application number
PT117825A
Other languages
Portuguese (pt)
Inventor
Borges Rodríguez
Manuel Romão De Castro Baltazar
Loureiro Martínez Julián
Emanuel Sampaio Dias Ivo
Perez Fernandez Román
Seoane Ruzo Samuel
Mouriño Mosquera Antonio
Original Assignee
Univ Santiago Compostela
Univ Do Porto
Requimte Rede De Quim E Tecnologia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Santiago Compostela, Univ Do Porto, Requimte Rede De Quim E Tecnologia filed Critical Univ Santiago Compostela
Priority to PT117825A priority Critical patent/PT117825A/en
Priority to PCT/IB2022/052839 priority patent/WO2023161688A1/en
Priority to ES202330169A priority patent/ES2946255B2/en
Publication of PT117825A publication Critical patent/PT117825A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F11/00—Compounds containing elements of Groups 6 or 16 of the Periodic Table
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/0825—Preparations of compounds not comprising Si-Si or Si-cyano linkages
    • C07F7/0827—Syntheses with formation of a Si-C bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0803—Compounds with Si-C or Si-Si linkages
    • C07F7/0825—Preparations of compounds not comprising Si-Si or Si-cyano linkages
    • C07F7/083—Syntheses without formation of a Si-C bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0834—Compounds having one or more O-Si linkage
    • C07F7/0836—Compounds with one or more Si-OH or Si-O-metal linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/0896—Compounds with a Si-H linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

O PRESENTE PEDIDO DESCREVE A SÍNTESE E IMPORTANTES APLICAÇÕES BIOLÓGICAS DE NOVOS ANÁLOGOS DA VITAMINA D BASEADOS NA TROCA DE CARBONO POR SILÍCIO NA CADEIA LATERAL DA HORMONA NATURAL E SEUS ANÁLOGOS. EM COMPARAÇÃO COM O METABOLITO NATURAL 1Α,25-DI-HIDROXIVITAMINA D3 (1,25D) DO RECETOR DA VITAMINA D (VDR), OS PRINCIPAIS RESULTADOS BIOLÓGICOS DESSES NOVOS DERIVADOS INDICAM QUE: A) ESTES ANÁLOGOS APRESENTAM UMA DIFERENCIAÇÃO CELULAR SEMELHANTE, B) A PROLIFERAÇÃO DE LINHAS DE CÉLULAS TUMORAIS É SIGNIFICATIVAMENTE MENOR, C) GRANDE CAPACIDADE DE ATIVAR GENES-ALVO DA 1,25D E D) ALTA AFINIDADE AO VDR. ALÉM DISSO, UM DOS ANÁLOGOS INDUZ UM AUMENTO SIGNIFICATIVO NO PESO DE ALGUNS ANIMAIS, O QUE PODE SUGERIR UM AUMENTO NA DENSIDADE ÓSSEA.THIS APPLICATION DESCRIBES THE SYNTHESIS AND IMPORTANT BIOLOGICAL APPLICATIONS OF NEW VITAMIN D ANALOGS BASED ON THE EXCHANGE OF CARBON FOR SILICON IN THE SIDE CHAIN OF THE NATURAL HORMONE AND ITS ANALOGS. IN COMPARISON WITH THE NATURAL METABOLITE 1Α,25-DIHYDROXIVITAMIN D3 (1,25D) OF THE VITAMIN D RECEPTOR (VDR), THE MAIN BIOLOGICAL RESULTS OF THESE NEW DERIVATIVES INDICATE THAT: A) THESE ANALOGS SHOW SIMILAR CELLULAR DIFFERENTIATION, B) THE PROLIFERATION OF TUMOR CELL LINES IS SIGNIFICANTLY LOWER, C) GREAT CAPACITY TO ACTIVATE 1,25D TARGET GENES AND D) HIGH AFFINITY TO THE VDR. IN ADDITION, ONE OF THE ANALOGS INDUCES A SIGNIFICANT INCREASE IN THE WEIGHT OF SOME ANIMALS, WHICH MAY SUGGEST AN INCREASE IN BONE DENSITY.

PT117825A 2022-02-28 2022-02-28 SILA-ANALOGS OF VITAMIN D, METHOD OF PRODUCTION OF SAID COMPOUNDS, USES THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUNDS PT117825A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
PT117825A PT117825A (en) 2022-02-28 2022-02-28 SILA-ANALOGS OF VITAMIN D, METHOD OF PRODUCTION OF SAID COMPOUNDS, USES THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUNDS
PCT/IB2022/052839 WO2023161688A1 (en) 2022-02-28 2022-03-28 Sila-analogues of vitamin d compounds, method of producing said compounds and uses thereof
ES202330169A ES2946255B2 (en) 2022-02-28 2023-02-27 SILA-ANALOGUES OF VITAMIN D COMPOUNDS, METHOD OF PRODUCTION OF SUCH COMPOUNDS AND USES THEREOF

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PT117825A PT117825A (en) 2022-02-28 2022-02-28 SILA-ANALOGS OF VITAMIN D, METHOD OF PRODUCTION OF SAID COMPOUNDS, USES THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUNDS

Publications (1)

Publication Number Publication Date
PT117825A true PT117825A (en) 2023-09-20

Family

ID=81648787

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117825A PT117825A (en) 2022-02-28 2022-02-28 SILA-ANALOGS OF VITAMIN D, METHOD OF PRODUCTION OF SAID COMPOUNDS, USES THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUNDS

Country Status (3)

Country Link
ES (1) ES2946255B2 (en)
PT (1) PT117825A (en)
WO (1) WO2023161688A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006074227A2 (en) * 2005-01-04 2006-07-13 Johns Hopkins University HIGHLY ANTIPROLIFERATIVE, LOW-CALCEMIC, ANALOGS OF THE HORMONE 1α, 25-DIHYDROXYVITAMIN D3 WITH CARBONYL SIDE CHAINS
EP2682386B1 (en) * 2011-03-02 2016-08-17 Nihon University Novel vitamin d receptor modulator with partial agonist activity
ES2396524B2 (en) * 2012-12-11 2013-08-01 Universidade De Santiago De Compostela Versatile and functionalized intermediates in the synthesis of vitamin D and new vitamin D derivatives
WO2019106214A1 (en) * 2017-11-29 2019-06-06 Universidade De Santiago De Compostela Compounds derived from vitamin d
ES2714628B2 (en) * 2017-11-29 2019-10-02 Univ Santiago Compostela Compounds derived from vitamin D
ES2759698A1 (en) * 2018-11-09 2020-05-11 Univ Santiago Compostela COMPOUNDS DERIVED FROM VITAMIN D (Machine-translation by Google Translate, not legally binding)

Also Published As

Publication number Publication date
WO2023161688A1 (en) 2023-08-31
ES2946255A1 (en) 2023-07-14
ES2946255B2 (en) 2024-08-16

Similar Documents

Publication Publication Date Title
Schwaller et al. ‘New’functions for ‘old’proteins: the role of the calcium-binding proteins calbindin D-28k, calretinin and parvalbumin, in cerebellar physiology. Studies with knockout mice
Jeong et al. Tetrahydrobiopterin improves diastolic dysfunction by reversing changes in myofilament properties
Tomaszewska et al. The influence of the dietary cu-glycine complex on the histomorphology of cancellous bone, articular cartilage, and growth plate as well as bone mechanical and geometric parameters is dose dependent
Iwamoto et al. Effects of vitamin K 2 on cortical and cancellous bone mass, cortical osteocyte and lacunar system, and porosity in sciatic neurectomized rats
Kim et al. Modulation of FoxO1 phosphorylation/acetylation by baicalin during aging
Johansen et al. 1α, 25-dihydroxyvitamin D3 stimulates activator protein 1 DNA-binding activity by a phosphatidylinositol 3-kinase/Ras/MEK/extracellular signal regulated kinase 1/2 and c-Jun N-terminal kinase 1-dependent increase in c-Fos, Fra1, and c-Jun expression in human keratinocytes
Akbari Moghaddam Kakhki et al. Medullary bone attributes in aged Lohmann LSL-lite layers fed different levels of calcium and top-dressed 25-hydroxy vitamin D3
Castro et al. The effect of total sulfur amino acid levels on growth performance and bone metabolism in pullets under heat stress
PT117825A (en) SILA-ANALOGS OF VITAMIN D, METHOD OF PRODUCTION OF SAID COMPOUNDS, USES THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE COMPOUNDS
Zhang et al. Effect of resveratrol on skeletal slow-twitch muscle fiber expression via AMPK/PGC-1α signaling pathway in bovine myotubes
Wang et al. Quercetin regulates calcium and phosphorus metabolism through the Wnt signaling pathway in broilers
Ryan et al. Alterations in vitamin D metabolite, parathyroid hormone and fibroblast growth factor-23 concentrations in sclerostin-deficient mice permit the maintenance of a high bone mass
Tomaszewska et al. Is dietary 2-oxoglutaric acid effective in accelerating bone growth and development in experimentally-induced intrauterine growth retarded gilts?
Lancaster et al. 24, 25-Dihydroxyvitamin D3 cooperates with a stable, fluoromethylene LPA receptor agonist to secure human (MG63) osteoblast maturation
Turner et al. Calvarial cells synthesize 1. alpha., 25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3
Fu et al. Dietary supplementation with sodium bicarbonate or sodium sulfate affects eggshell quality by altering ultrastructure and components in laying hens
Belkameh et al. The effect of different levels of dietary magnesium on eggshell quality and laying hen’s performance
Dong et al. Vitamin D supplementation for osteoporosis in older adults: can we make it help better?
Zlotkowski et al. Small-molecule-mediated axonal branching in Caenorhabditis elegans
Mendez-Davila et al. Effects of 17β-estradiol, tamoxifen and raloxifene on the protein and mRNA expression of interleukin-6, transforming growth factor-β1 and insulin-like growth factor-1 in primary human osteoblast cultures
Zhang et al. Exploring the mechanism of tenghuang jiangu wan in osteoporosis treatment based on network pharmacology, molecular docking and experimental pharmacology
Pechanec et al. Evaluation and optimization of a three-dimensional construct model for equine superficial digital flexor tendon
DeLuca et al. Selective analogs of 1α, 25-dihydroxyvitamin D3 for the study of specific functions of Vitamin D
Wang et al. Calcium-fortified fresh milk ameliorates postmenopausal osteoporosis via regulation of bone metabolism and gut microbiota in ovariectomized rats
Zaychenko et al. Influence of different resveratrol dosage forms оn indicators of endogenous neuroprotection in experimental hypoestrogenic state

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 20230915